Crossmark Global Holdings, Inc. Galapagos Nv Transaction History
Crossmark Global Holdings, Inc.
- $5.49 Billion
- Q4 2024
A detailed history of Crossmark Global Holdings, Inc. transactions in Galapagos Nv stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 49,163 shares of GLPG stock, worth $1.14 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
49,163
Previous 37,386
31.5%
Holding current value
$1.14 Million
Previous $1.08 Million
25.53%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding GLPG
# of Institutions
85Shares Held
12.3MCall Options Held
69.1KPut Options Held
42.7K-
Bvf Inc San Francisco, CA1.57MShares$36.4 Million1.44% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.41MShares$32.7 Million0.76% of portfolio
-
Prosight Management, LP Dallas, TX1.03MShares$23.8 Million7.95% of portfolio
-
Logos Global Management LP San Francisco, CA800KShares$18.5 Million3.05% of portfolio
-
Primecap Management CO Pasadena, CA720KShares$16.7 Million0.02% of portfolio
About GALAPAGOS NV
- Ticker GLPG
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,835,500
- Market Cap $1.53B
- Description
- Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...